Medtronic HVAD Recall Given High-Risk Class I Designation

A welding defect may allow moisture to enter affected heart pumps, which can lead to device failure, the US FDA explained. Medtronic first announced the recall in April. 

Digital model of the heart.
• Source: Shutterstock

A recall of Medtronic’s Heartware Ventricular Assist Device (HVAD) pump implant kit has been slapped with high-risk class I status by the US Food and Drug Administration, the agency announced on 8 June.

The system, which helps the heart continue to pump blood, is used both as a bridge to cardiac transplant for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Recalls

More from Policy & Regulation